Blueprint for a breakthrough: Applying research learnings beyond the lab
April 07, 2021
Blueprint for a breakthrough: Applying research learnings beyond the lab
Confronting the complexities of cancer
April 06, 2021
Confronting the complexities of cancer
Cell therapy’s got talent – and is looking for more
March 05, 2021
Cell therapy’s got talent – and is looking for more
February 08, 2021
Get to know JAK2 and its role in Myelofibrosis
2020 Global Virtual Cancer Conference
December 07, 2020
Health Equity Takes Center Stage at the 2020 Global Virtual Cancer Conference
Cell Therapy: Looking to the Future of CAR T
November 11, 2020
Cell Therapy: Looking to the Future of CAR T
Building on Today’s Science to Research Medicines of Tomorrow
November 08, 2020
Building on today’s science to research medicines of tomorrow
Taking a Comprehensive Approach to Treat the Biology of  Cancer
September 08, 2020
Taking a Comprehensive Approach to Treat the Biology of Cancer
Advancing Acute Myeloid Leukemia Research through Epigenetics
August 31, 2020
Advancing Acute Myeloid Leukemia Research through Epigenetics
What Is Myelodysplastic Syndrome? Is MDS a Form of Cancer?
August 18, 2020
What Is Myelodysplastic Syndrome? Is MDS a Form of Cancer?
Rupert Vessey, head of Research and Early Development, Bristol Myers Squibb, provides an overview of the company’s oncology research program for II-ON’s membership.
July 09, 2020
Uniting to take on cancer
Protein Homeostasis 101
May 26, 2020
Protein Homeostasis 101: A Q&A with Josh Hansen